Key result
Postoperative PRAM hemodynamic monitoring links low cardiac cycle efficiency to adverse 6-month events.
Why the study?
A short period of minimally invasive hemodynamic monitoring after cardiac surgery may improve identification of patients at higher risk of 6-month adverse events, which was evaluated in this study.
Does a short period of minimally invasive hemodynamic monitoring (PRAM) identify patients at higher risk of 6-month adverse events after cardiac surgery?
Observational (n=173)
Does a short period of minimally invasive hemodynamic monitoring (PRAM) identify patients at higher risk of 6-month adverse events after cardiac surgery?
A short period of minimally invasive hemodynamic monitoring using PRAM in the step-down unit improves the identification of patients at high risk for mid-term adverse events after cardiac surgery.
PRAM on SDU admission may identify higher-risk post-cardiac surgery patients; hypothesis-generating and requires prospective validation before clinical adoption.
Introduction: Studies have shown that a hemodynamic-guided therapy improves the post operative outcomes of high-risk patients.This study, evaluated if a short period through minimally invasive hemodynamic monitoring, pressure recording analytical method (PRAM), on admission to a post-cardiac surgery step-down unit (SDU), may identify patients at higher risk of 6-month adverse events after cardiac surgery. Methods: From December 2016-May 2017,173 patients were admitted in SDU within 24-48 hours of major cardiac surgery procedure, and submitted to clinical, laboratoristic and echocardiographic evaluation and a 1-hour PRAM recording to obtain a "biohumoral snapshot" of individual patient’s.156 173 patients (17 patients were lost at follow-up) were phone interviewed six months after surgery,to evaluate, as a composite end-point, the adverse events during follow-up. A multivariable logistic regression analysis was used to identify a model clinical-biohumoral (CBM) and clinical-biohumoral hemodynamics (CBHM). Results: No data from past clinical history and no conventional risk score (EuroScore II, STS score)independently predicted the risk of 6-month major events in our study. The risk of adverse events at six-month follow-up was directly related, in the CBM, to sustained post-operative cardiac arrhythmias, higher values of NT-proBNP and of arterial pH; inversely related to values of hs-C-reactive protein (hs-CRP) and, in the CBHM, to low values of cardiac cycle efficiency (CCE) and dP/dtmax. Conclusion: Our study although limited by its observational nature and by the limited number of patients enrolled, showed that a short period of minimally invasive hemodynamic monitoring increased the accuracy to identify patients at major risk of mid-term events after cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Giglioli et al. (2020) conducted an observational in Post-cardiac surgery (n=173). Minimally invasive hemodynamic monitoring (PRAM) was evaluated on Adverse events during 6-month follow-up. Minimally invasive hemodynamic monitoring (PRAM) identified patients at higher risk of 6-month adverse events after cardiac surgery, driven by low values of cardiac cycle efficiency and dP/dtmax.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: